Aktivitetsneutraliserende antistoffer (inhibitorer) er meget sjældne hos tidligere behandlede patienter, der får faktor IX- produkter.
Activity-neutralising antibodies (inhibitors) is a very rare event in previously treated patients receiving factor IX-containing products.